102 related articles for article (PubMed ID: 25212031)
1. [Development of a novel screening assay for inhibitors targeting HIF-1alpha and P300 interaction].
Lai FF; Niu F; Yang HZ; Zhou WQ; Chen XG
Yao Xue Xue Bao; 2014 Jun; 49(6):849-53. PubMed ID: 25212031
[TBL] [Abstract][Full Text] [Related]
2. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
[TBL] [Abstract][Full Text] [Related]
3. Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma.
Viziteu E; Grandmougin C; Goldschmidt H; Seckinger A; Hose D; Klein B; Moreaux J
Br J Cancer; 2016 Mar; 114(5):519-23. PubMed ID: 26867162
[TBL] [Abstract][Full Text] [Related]
4. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
Na YR; Han KC; Park H; Yang EG
Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
[TBL] [Abstract][Full Text] [Related]
5. Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.
Goey AK; Chau CH; Sissung TM; Cook KM; Venzon DJ; Castro A; Ransom TR; Henrich CJ; McKee TC; McMahon JB; Grkovic T; Cadelis MM; Copp BR; Gustafson KR; Figg WD
J Nat Prod; 2016 May; 79(5):1267-75. PubMed ID: 27140429
[TBL] [Abstract][Full Text] [Related]
6. Visualization of hypoxia-inducible factor 1α-p300 interactions in live cells by fluorescence resonance energy transfer.
Kim SY; Lee MJ; Na YR; Kim SY; Yang EG
J Cell Biochem; 2014 Feb; 115(2):271-80. PubMed ID: 23966271
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents.
Wei J; Yang Y; Lu M; Lei Y; Xu L; Jiang Z; Xu X; Guo X; Zhang X; Sun H; You Q
Mini Rev Med Chem; 2018; 18(4):296-309. PubMed ID: 27484627
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hypoxia-inducible factor-1 alpha radiosensitized MG-63 human osteosarcoma cells in vitro.
Jin Z; Aixi Y; Baiwen Q; Zonghuan L; Xiang H
Tumori; 2015; 101(5):578-84. PubMed ID: 26350185
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression.
Kessler J; Hahnel A; Wichmann H; Rot S; Kappler M; Bache M; Vordermark D
BMC Cancer; 2010 Nov; 10():605. PubMed ID: 21050481
[TBL] [Abstract][Full Text] [Related]
10. NF-κB suppresses HIF-1α response by competing for P300 binding.
Mendonça DB; Mendonça G; Aragão FJ; Cooper LF
Biochem Biophys Res Commun; 2011 Jan; 404(4):997-1003. PubMed ID: 21187066
[TBL] [Abstract][Full Text] [Related]
11. Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism.
Cook KM; Hilton ST; Mecinovic J; Motherwell WB; Figg WD; Schofield CJ
J Biol Chem; 2009 Sep; 284(39):26831-8. PubMed ID: 19589782
[TBL] [Abstract][Full Text] [Related]
12. Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction.
Yang C; Wang W; Li GD; Zhong HJ; Dong ZZ; Wong CY; Kwong DW; Ma DL; Leung CH
Sci Rep; 2017 Feb; 7():42860. PubMed ID: 28225008
[TBL] [Abstract][Full Text] [Related]
13. Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells.
Staab A; Loeffler J; Said HM; Diehlmann D; Katzer A; Beyer M; Fleischer M; Schwab F; Baier K; Einsele H; Flentje M; Vordermark D
BMC Cancer; 2007 Nov; 7():213. PubMed ID: 17999771
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1α-p300 interaction by a small molecule.
Kwon HS; Kim DR; Yang EG; Park YK; Ahn HC; Min SJ; Ahn DR
Bioorg Med Chem Lett; 2012 Aug; 22(16):5249-52. PubMed ID: 22789427
[TBL] [Abstract][Full Text] [Related]
15. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
[TBL] [Abstract][Full Text] [Related]
17. Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.
Li J; Xi W; Li X; Sun H; Li Y
Bioorg Med Chem; 2019 Apr; 27(7):1145-1158. PubMed ID: 30819620
[TBL] [Abstract][Full Text] [Related]
18. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
Yoon H; Lim JH; Cho CH; Huang LE; Park JW
Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
[TBL] [Abstract][Full Text] [Related]
19. Structural Elucidation and Synthesis of Eudistidine A: An Unusual Polycyclic Marine Alkaloid that Blocks Interaction of the Protein Binding Domains of p300 and HIF-1α.
Chan ST; Patel PR; Ransom TR; Henrich CJ; McKee TC; Goey AK; Cook KM; Figg WD; McMahon JB; Schnermann MJ; Gustafson KR
J Am Chem Soc; 2015 Apr; 137(16):5569-75. PubMed ID: 25892103
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1alpha blocks differentiation of malignant gliomas.
Lu H; Li Y; Shu M; Tang J; Huang Y; Zhou Y; Liang Y; Yan G
FEBS J; 2009 Dec; 276(24):7291-304. PubMed ID: 19912340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
